Fingerprint
Dive into the research topics of 'Treatment patterns and deep molecular response in chronic phase–chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically